Transcriptomics methodologies have enabled the simultaneous measurement of tens of thousands of genes in the muscles of both dystrophin-deficient animal models and DMD patient biopsy samples (36, , , –40). The gene discussed is DMD; the disease is Duchenne muscular dystrophy.